DH - NASDAQ
Definitive Healthcare Corp.
$0.90
+3.5%Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
At a Glance
Live SnapshotDefinitive Healthcare Corp. Management Team
Ms. Kate Hastings
Chief Customer Officer
Mr. Kevin D. Coop
Chief Executive Officer & Director
Compensation
$711,242
Mr. Richard Douglas Booth CPA
Chief Financial Officer
Compensation
$491,247
Mr. Matthew Ruderman
Chief Legal Officer & Secretary
Ms. Kate Marie Shamsuddin Jensen
Chief Operating Officer
Compensation
$417,629
Mr. Benjamin Graboske
EVice President, Technology, Engineering & Chief Data Officer
Mr. Jason Ronald Krantz
Founder & Executive Chairman
Compensation
$174,664
Ms. Rebecca Marani
GM & Senior Vice President of Provider
Ms. Casey Heller
Senior Vice President of Finance
Ms. Michelle Liro
Senior Vice President of Marketing
Definitive Healthcare Corp. Insider Positioning
During the last 12 months, insiders have sold $820K worth of DH shares, with no buying activity reported.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
70.0K
235.87K
-236K
-$236K
9-12 Months
0
0.00
146.6K
584.15K
-584K
-$584K
Top Buyers
No buying activity
Top Sellers
Coop Kevin
Director, Officer: Chief Executive Officer
$607K
Krantz Jason Ronald
Director, 10 Percent Owner, Other: Executive Chairman
$154K
Heller Casey
Officer: Chief Financial Officer
$38K
Shamsuddin Kate Marie
Officer: Chief Operating Officer
$21K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $820K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Insider Participation
4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
SEC Filings
DH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | June 04, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 23, 2025 | June 05, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 09, 2024 | May 22, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 20, 2023 | April 20, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 12, 2022 | May 24, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.